Antibiotic-driven and microbiota-targeted therapy for advanced management of pulmonary hypertension

Antibiotic-driven microbiota modulation may alleviate PH progression by targeting dysbiosis and reducing inflammation. These findings support further investigation into optimized antibiotic regimens as a therapeutic strategy for PH, particularly in hypoxic lung disease-associated cases.

Authors

Institutions

Publication Details

Journal
Respiratory Research
Published
2025-10-31
DOI
https://doi.org/10.1186/s12931-025-03362-y
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antibiotic-driven and microbiota-targeted therapy for advanced management of pulmonary hypertension

Wenju Lu, Chenting Zhang, Xiaosong Ben, Yue Xing et al.
Respiratory Research
Pulmonary Hypertension Research and Treatments
article

Antibiotic-driven and microbiota-targeted therapy for advanced management of pulmonary hypertension

Wenju Lu, Chenting Zhang, Xiaosong Ben, Yue Xing, Kai Yang, Jason X.‐J. Yuan, Wei-feng Zhan, Ziying Lin, Jian Wang, Ting Wang, Chunli Liu, Jiang Qian, Biao Hu, Han Yan, Jiyuan Chen, Dansha Zhou, Aofeng Liu
article en

Abstract

Antibiotic-driven microbiota modulation may alleviate PH progression by targeting dysbiosis and reducing inflammation. These findings support further investigation into optimized antibiotic regimens as a therapeutic strategy for PH, particularly in hypoxic lung disease-associated cases.

Respiratory ResearchVol. 26(1)
Scripps Research Institute (US), Guangzhou Experimental Station (CN), First Affiliated Hospital of Guangzhou Medical University (CN), Nanfang Hospital (CN), Guangdong Academy of Medical Sciences (CN), State Key Laboratory of Respiratory Disease (CN), Children's Hospital of Chongqing Medical University (CN), Southern Medical University (CN), Chongqing Medical University (CN), Guangzhou Medical University (CN)
Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Natural Science Foundation of China, Guangdong Provincial Pearl River Talents Program, Guangzhou Municipal Science and Technology Project
Openalex Percentile: Top 55%
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.